Jorge Malouf

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi et al. · The Lancet Diabetes & Endocrinology · 2017 · 961 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Bente Langdahl, Cesar Libanati, Daria B. Crittenden et al. · The Lancet · 2017 · 467 citations

Medicine, Endocrinology, Pharmacotherapy +14

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates

Paul D. Miller, Nicola Pannacciulli, Jacques P. Brown et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 234 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial

Eva Román, Cristina García-Galcerán, Teresa Torrades et al. · PLoS ONE · 2016 · 153 citations · Full text

Medicine, Physiology, Rehabilitation Medicine +17

3D-DXA: Assessing the Femoral Shape, the Trabecular Macrostructure and the Cortex in 3D from DXA images

Ludovic Humbert, Y. Martelli, Roger Fonollà et al. · IEEE Transactions on Medical Imaging · 2016 · 132 citations

Dentistry, Orthopaedic Surgery, Orthopedic Surgery +17